Brief: Epirus Biopharmaceuticals - entered into at-the-market sales agreement pursuant to which company may sell up to $30 mln in shares
01/03/2016 11:13
March 1 (Reuters) - EPIRUS Biopharmaceuticals Inc EPRS.O : * Entered into at-the-market sales agreement pursuant to which company may sell up to $30 million in shares * Source text for Eikon urn:newsml:reuters.com:*:nWNAB0A7MG * Further company coverage EPRS.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Epirus Biopharmaceuticals
See all newsBrief: Epirus Biopharmaceuticals entered settlement satisfaction amendment with Livzon Mabpharm
Brief: Jennison Associates dissolves passive stake in Epirus Biopharmaceuticals
Brief: Epirus Biopharmaceuticals enters term sheet with Zaklady Farmaceutyczne
Brief: Epirus Biopharmaceuticals announces reprioritization of pipeline
Brief: Epirus biopharmaceuticals files for non-timely 10-k - sec filing